Upstate Active Clinical Trials

Study Title:

A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects with Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms.

What is the purpose of the study? (in Layman's terms, please describe the study)

To determine whether daptomycin is effective and safe in the treatment of pediatric subjects with Acute Hematogenous Osteomyelitis (AHO) when compared to vancomycin (or equivalent) or nafcillin (or beta-lactam equivalent).

Upstate Institutional Review Board (IRB) Number:

484796

Study/Protocol ID:

DAP-PEDOST-11-03

Study Phase:

3

Patient Age Group:

Children

Principal Investigator:

Leonard B Weiner

ClinicalTrials.Gov ID:

NCT01922011

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Wendy A Holz
Phone: 315-464-7562
Email: holzw@upstate.edu

Return to Previous Page || Search Again